References
- Fox KM, Ford I, Steg PG et al. Heart rate as a prognostic risk factor in patients with coronary artery disease and left ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet372, 817–821 (2008).
- Kjekshus J, Apertrei E, Barrios et al. Rosuvastatin in older patients with heart failure. N. Engl. J. Med.357, 2248–2261 (2007).
- Marchioli R, Barzi F, Bomba E et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time course analysis of the results of the Gruppo Italiano per lo Studio Sopravvivenza nell’Infarto Micocardico (GISSI) – Prevenzione. Circulation105, 1897–1903 (2002).
- Booth J, Clayton J, Pepper J et al. Randomized, controlled trial of coronary bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease – six year follow-up of the Stent or Surgery trial (SoS). Circulation118, 381–388 (2008).
- Damman K, Navis G, Voors AA et al. Worsening renal function and prognosis in heart failure: systematic review and meta analysis. J. Card. Fail.13, 599–608 (2007).
- Dar OA, Riley JA, Chapman C et al. Telemonitoring in an elderly, urban, multi-ethnic population: results of a UK multi centre randomised controlled trial. The Home Heart Failure (HOME HF) Study. Eur. Heart. J.29, 381 (2008).
- Donahue T, Niazi I, Leon A et al. Chronic evaluation of CRT in narrow QRS patients with mechanical dyssynchrony from a multi center Study: ESTEEM-CRT. Eur. Heart. J.29, 732 (2008).